Measurement of derivatives of proinsulin-like growth factor-II in serum by a radioimmunoassay directed against the E-domain in normal subjects and patients with nonislet cell tumor hypoglycemia.
暂无分享,去创建一个
[1] W. Daughaday,et al. Heterogeneity of serum peptides with immunoactivity detected by a radioimmunoassay for proinsulin-like growth factor-II E domain: description of a free E domain peptide in serum. , 1992, Journal of Clinical Endocrinology and Metabolism.
[2] R. Baxter,et al. Impaired formation of the ternary insulin-like growth factor-binding protein complex in patients with hypoglycemia due to nonislet cell tumors. , 1991, The Journal of clinical endocrinology and metabolism.
[3] W. Lee,et al. Measurement of insulin-like growth factor-II in physiological fluids and tissues. II. Extraction quantification in rat tissues. , 1991, Endocrinology.
[4] W. Lee,et al. Measurement of insulin-like growth factor-II in physiological fluids and tissues. I. An improved extraction procedure and radioimmunoassay for human and rat fluids. , 1991, Endocrinology.
[5] W. R. Hudgins,et al. Development of a specific radioimmuno assay for E domain containing forms of insulin-like growth factor II. , 1991, Advances in experimental medicine and biology.
[6] W. Daughaday,et al. Abnormal processing of pro-IGF-II in patients with hepatoma and in some hepatitis B virus antibody-positive asymptomatic individuals. , 1990, The Journal of laboratory and clinical medicine.
[7] M. Israel,et al. Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. , 1989, The Journal of clinical investigation.
[8] W. Daughaday,et al. Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[9] P. Roholl,et al. Expression of insulin‐like growth factor‐I and ‐II genes in human smooth muscle tumours. , 1988, The EMBO journal.
[10] D. Hill,et al. Purification and characterization of a unique high molecular weight form of insulin-like growth factor II. , 1987, Endocrinology.
[11] J. Irminger,et al. Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms tumors: expression at the mRNA and protein level. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[12] W. Daughaday. [24] Radioligand assays for insulin-like growth factor II , 1987 .
[13] T. Merimee,et al. Insulin-like growth factors in patients with nonislet cell tumors and hypoglycemia. , 1986, Metabolism: clinical and experimental.
[14] J. Scott,et al. Insulin-like growth factor-II gene expression in Wilms' tumour and embryonic tissues , 1985, Nature.
[15] M. Eccles,et al. Expression of insulin-like growth factor-II transcripts in Wilms' tumour , 1985, Nature.
[16] P. Zumstein,et al. Amino acid sequence of a variant pro-form of insulin-like growth factor II. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[17] M. Svoboda,et al. [61] Purification of somatomedin-C/insulin-like growth factor I , 1985 .
[18] R. Humbel,et al. Evidence for two species of insulin-like growth factor II (IGF II and "big" IGF II) in human spinal fluid. , 1982, Endocrinology.
[19] W. Daughaday,et al. Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. , 1980, The Journal of clinical endocrinology and metabolism.